{"id":45030,"date":"2023-03-10T10:47:25","date_gmt":"2023-03-10T10:47:25","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=45030"},"modified":"2023-03-28T08:27:19","modified_gmt":"2023-03-28T08:27:19","slug":"croi-2023-first-reports","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/45030","title":{"rendered":"30th Conference on Retroviruses and OIs (CROI 2023): first reports"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead2articletitle\"><strong>19\u201323 February 2022, Seattle and virtual<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\">Simon Collins, HIV i-Base<\/span><\/strong><\/p>\n<h2>Introduction<\/h2>\n<\/div>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-44826 alignright\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2023\/02\/CROI-2023-logo-222x300.png\" alt=\"\" width=\"185\" height=\"247\" \/>This year the annual Conference on Retroviruses and Opportunistic Infections (CROI) was held in Seattle from 19\u201322 February, and also virtually.<\/strong><\/p>\n<p>This was the 30th meeting, and as usual the programme included important studies on all aspects of HIV care, also covering COVID and mpox.<\/p>\n<p>The programme and abstracts are already online as open access.<br \/>\n<a href=\"https:\/\/www.croiconference.org\/preliminary-agenda\">https:\/\/www.croiconference.org\/preliminary-agenda<\/a> (programme)<br \/>\n<a href=\"https:\/\/www.croiconference.org\/search-abstracts\">https:\/\/www.croiconference.org\/search-abstracts<\/a> (searchable abstract database)<\/p>\n<div>\n<p class=\"HTBBODYtext\">All other conference material including webcasts of all oral presentations will become open-access a month after the meeting.<\/p>\n<\/div>\n<div>Early reports in this issue of HTB are linked below &#8211; and more will be posted as they become available.<\/div>\n<div>\n<p>CROI 2023: ANTIRETROVIRALS<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/44935\" rel=\"bookmark\">Pipeline HIV drugs and formulations for treatment and PrEP<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/44865\" rel=\"bookmark\">Six-monthly ART \u2013 lenacapavir + dual bNAbs maintains undetectable viral load for 26 weeks after single doses<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/44901\" rel=\"bookmark\">Other lenacapavir studies \u2013 experienced and naive updates, the dosing window, HIV-2 and PrEP<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/44944\" rel=\"bookmark\">Similar PK profile for thigh vs gluteal CAB\/RPV-LA injections: accidental intravenous injection<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/44950\" rel=\"bookmark\"> Efficacy of N6LS monotherapy correlated with baseline factors<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/45024\" rel=\"bookmark\">CAB\/RPV-LA levels are not reduced after switching from efavirenz<\/a><\/li>\n<\/ul>\n<p>CROI 2023: TREATMENT STRATEGIES<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/44850\" rel=\"bookmark\">Yet more evidence for recycled tenofovir and 3TC or FTC with dolutegravir in second-line: 48 week results from the D2EFT study<\/a><\/li>\n<\/ul>\n<p>CROI 2023: PREGNANCY<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/45015\" rel=\"bookmark\">Point-of-care testing for mothers and infants: results from the LIFE study<\/a><\/li>\n<\/ul>\n<p>CROI 2023: SIDE EFFECTS<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/44981\" rel=\"bookmark\">Bone density profiles for CAB-LA vs TDF\/FTC oral PrEP in young people<\/a><\/li>\n<\/ul>\n<p>CROI 2023: COMPLICATIONS<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/44912\" rel=\"bookmark\">Single dose doxycycline as PEP for STIs (DoxyPEP): five studies<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/44839\" rel=\"bookmark\">Severe mpox outcomes with a low CD4 count and detectable viral load: a new AIDS-defining condition?<\/a><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>19\u201323 February 2022, Seattle and virtual Simon Collins, HIV i-Base Introduction This year the annual Conference on Retroviruses and Opportunistic Infections (CROI) was held in Seattle from 19\u201322 February, and also virtually. This was the 30th meeting, and as usual &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,327],"class_list":["post-45030","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2023"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/45030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=45030"}],"version-history":[{"count":10,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/45030\/revisions"}],"predecessor-version":[{"id":45128,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/45030\/revisions\/45128"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=45030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=45030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=45030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}